Arrowhead Pharmaceuticals, Inc.
ARWR
$82.63
-$2.48-2.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.60B | 1.78B | 914.71M | 917.47M | 898.17M |
| Total Receivables | 18.79M | 15.69M | 218.87M | 6.82M | 9.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.37M | 21.72M | 16.05M | 10.93M | 23.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.39M | 20.15M | 24.76M | 15.42M | 15.36M |
| Total Current Assets | 1.67B | 1.84B | 1.17B | 950.64M | 946.92M |
|
|
|||||
| Total Current Assets | 1.67B | 1.84B | 1.17B | 950.64M | 946.92M |
| Net Property, Plant & Equipment | 428.97M | 417.62M | 421.95M | 426.41M | 425.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.59M | 6.01M | 6.44M | 6.86M | 7.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.85M | 187.00K | 1.41M | 1.39M | 1.35M |
| Total Assets | 2.11B | 2.27B | 1.60B | 1.39B | 1.38B |
|
|
|||||
| Total Accounts Payable | 27.78M | 30.75M | 32.94M | 17.67M | 33.05M |
| Total Accrued Expenses | 106.44M | 94.51M | 92.78M | 96.24M | 83.77M |
| Short-term Debt | 3.20M | 10.50M | 10.40M | 10.30M | 7.10M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.32M | 47.77M | 47.53M | 47.29M | 47.01M |
| Total Finance Division Other Current Liabilities | 100.61M | 111.69M | 163.78M | 23.99M | 23.60M |
| Total Other Current Liabilities | 100.61M | 111.69M | 163.78M | 23.99M | 23.60M |
| Total Current Liabilities | 283.35M | 295.22M | 347.43M | 195.49M | 194.53M |
|
|
|||||
| Total Current Liabilities | 283.35M | 295.22M | 347.43M | 195.49M | 194.53M |
| Long-Term Debt | 1.22B | 1.23B | 538.11M | 582.28M | 560.59M |
| Short-term Debt | 3.20M | 10.50M | 10.40M | 10.30M | 7.10M |
| Capital Leases | 114.30M | 100.11M | 102.13M | 104.11M | 105.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.74M | 48.62M | 53.83M | -- | -- |
| Total Liabilities | 1.65B | 1.67B | 1.04B | 881.88M | 860.81M |
|
|
|||||
| Common Stock & APIC | 2.44B | 2.40B | 2.21B | 2.14B | 2.12B |
| Retained Earnings | -1.92B | -1.73B | -1.60B | -1.63B | -1.60B |
| Treasury Stock & Other | -54.43M | -52.45M | -46.49M | -46.75M | 5.36M |
| Total Common Equity | 465.53M | 613.98M | 568.42M | 466.05M | 522.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 465.53M | 613.98M | 568.42M | 466.05M | 522.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 512.00K | -15.06M | -5.73M | 37.36M | -2.51M |
| Total Equity | 466.04M | 598.92M | 562.70M | 503.42M | 519.81M |
|
|
|||||